Antagonizing the cannabinoid receptor type 1: a dual way to fight obesity

J Endocrinol Invest. 2003 Oct;26(10):1041-4. doi: 10.1007/BF03348205.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Energy Intake / physiology
  • Energy Metabolism / physiology
  • Feeding Behavior / physiology
  • Humans
  • Obesity / drug therapy*
  • Piperidines / pharmacology*
  • Piperidines / therapeutic use
  • Pyrazoles / pharmacology*
  • Pyrazoles / therapeutic use
  • Receptor, Cannabinoid, CB1 / antagonists & inhibitors*
  • Receptors, Drug / antagonists & inhibitors
  • Rimonabant

Substances

  • Piperidines
  • Pyrazoles
  • Receptor, Cannabinoid, CB1
  • Receptors, Drug
  • Rimonabant